PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.19%
Revenue growth under 50% of 1113.HK's 63.14%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
0.62%
Gross profit growth under 50% of 1113.HK's 55.84%. Michael Burry would be concerned about a severe competitive disadvantage.
-184.03%
Negative EBIT growth while 1113.HK is at 50.64%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-269.98%
Negative operating income growth while 1113.HK is at 54.23%. Joel Greenblatt would press for urgent turnaround measures.
-184.58%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-188.40%
Negative EPS growth while 1113.HK is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-188.40%
Negative diluted EPS growth while 1113.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.15%
Slight or no buybacks while 1113.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-4.03%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
262.25%
OCF growth under 50% of 1113.HK's 1111.89%. Michael Burry might suspect questionable revenue recognition or rising costs.
607.60%
FCF growth 50-75% of 1113.HK's 996.30%. Martin Whitman would see if structural disadvantages exist in generating free cash.
619104.39%
10Y revenue/share CAGR above 1.5x 1113.HK's 342.72%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1092.96%
5Y revenue/share CAGR above 1.5x 1113.HK's 0.59%. David Dodd would look for consistent product or market expansions fueling outperformance.
181.58%
3Y revenue/share CAGR above 1.5x 1113.HK's 21.11%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-38.63%
Negative 10Y OCF/share CAGR while 1113.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
260.50%
5Y OCF/share CAGR above 1.5x 1113.HK's 32.14%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
283.47%
3Y OCF/share CAGR under 50% of 1113.HK's 620.48%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-358.45%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
45.57%
Positive 5Y CAGR while 1113.HK is negative. John Neff might view this as a strong mid-term relative advantage.
-1162.13%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
152.31%
Below 50% of 1113.HK's 1825.85%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-8.90%
Negative 5Y equity/share growth while 1113.HK is at 44.89%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
7.04%
3Y equity/share CAGR at 50-75% of 1113.HK's 12.31%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-42.33%
Cut dividends over 10 years while 1113.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.08%
Inventory shrinking or stable vs. 1113.HK's 18.84%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
5.43%
Asset growth 1.25-1.5x 1113.HK's 3.97%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
-7.19%
We have a declining book value while 1113.HK shows 6.15%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
39.38%
Debt growth far above 1113.HK's 5.34%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
31.23%
We expand SG&A while 1113.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.